Last updated on July 2020

A Clinical Study to Evaluate the Efficacy and Safety of CKD-351


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Eye Disease | Eye Disorders/Infections | Eye Disorders/Infections (Pediatric) | Ocular Hypertension | Open Angle Glaucoma | Glaucoma | EYE DISORDER | Dry Eye Disease | Pigmentary glaucoma | Primary Open Angle Glaucoma
  • Age: Between 19 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. More than the age of 19 years old
  2. Subjects who has primary open-angle glaucoma or ocular hypertension
  3. Subjects who sign on an informed consent form willingly

Exclusion Criteria:

  1. Subjects with intraocular pressure 35 mmHg at Visit 1 or Visit 2 (AM 09:00)
  2. Subjects with a maximum corrected visual acuity 0.3 in the selected evaluation eye at Visit 1 or Visit 2
  3. Subjects who were diagnosed as below
    • Aphakia
    • Intraocular lens
    • Acute or Chronic Closed-Angle Glaucoma
    • Secondary Glaucoma
  4. Subjects with ocular inflammation or infection within the last 3 months
  5. Subjects with significant history of ocular trauma during the last 6 months or who underwent surgical opthalmic surgery
  6. Subjects who received topical or systemic steroids within the last 1 month.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.